fda removes semaglutide from drug shortage list february 21 2025 US judge upholds FDA's removal of Ozempic, Wegovy Semaglutide shortage ends as FDA

Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity

Many users find this duration ideal for achieving their target weight while building confidence in their new habits

I felt like my old self again, I had been losing and regaining weight for years, but this was finally sticking

Seek qualified care If symptoms include severe shortness of breath, chest pain, or signs of an allergic reaction, stop immediately and seek qualified medical care